Does instant coffee prevent acute liver injury induced by carbon tetrachloride (CCl4)?

Hepatology Research

Volumn 35, Issue 3, 2006, Pages 163-168

  Ozercan, Ibrahim Hanifi ^a   Dagli, Adile Ferda ^a   Ustundag, Bilal ^a   Ozercan, Mehmet Resat ^a   Bahcecioglu, Ibrahim Halil ^a   Çelik, Hakim ^b   Yalniz, Mehmet ^a   Poyrazoglu, Orhan Kursat ^a   Ataseven, Huseyin ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Acute liver injury; Antioxidant; Instant coffee; Lipid peroxidation

Indexed keywords

CARBON TETRACHLORIDE; CERULOPLASMIN; MALONALDEHYDE; THIOL GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COFFEE; CONTROLLED STUDY; FATTY LIVER; HEPATITIS; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 33745713937     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2006.04.004     Document Type: Article

References (46)

1. Mursu J., Voutilainen S., Nurmi T., et al. The effects of coffee consumption on lipid peroxidation and plasma total homocysteine concentrations: a clinical trial. Free Radic Biol Med 38 (2005) 527-534
2. Tverdal A., and Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 13 (2003) 419-423
3. Gelatti U., Covolo L., Franceschini M., et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 42 (2005) 528-534
4. Gallus S., Tavani A., Negri E., and La Vecchia C. Does coffee protect against liver cirrhosis?. Ann Epidemiol 12 (2002) 202-205
5. Cavin C., Holzhaeuser D., Scharf G., Constable A., Huber W.W., and Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40 (2002) 1155-1163
6. Corrao G., Zambon A., Bagnardi V., D'Amicis A., and Klatsky A. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 11 (2001) 458-465
7. Honjo S., Kono S., Coleman M.P., et al. Coffee drinking and serum gamma-glutamyltransferase: an extended study of self-defense officials of Japan. Ann Epidemiol 9 (1999) 325-331
8. Chen A.S., Taguchi T., Sakai K., Matahira Y., Wang M.W., and Miwa I. Effect of chitobiose and chitotriose on carbon tetrachloride-induced acute hepatotoxicity in rats. Biol Pharm Bull 28 (2005) 1971-1973
9. 4) ile deneysel olarak karaciǧer nekrozu oluşturulan ratlarda Vitamin E + selenyum ve Nigella sativa (çörekotu)'nun karaciǧer yi{dotless}ki{dotless}mi{dotless}ni{dotless} engelleyici etkileri. Turk J Vet Anim Sci 27 (2003) 141-152
10. Lam L.K., Sparnins V.L., and Wattenberg L.W. Effects of derivatives of kahweol and cafestol on the activity of glutathione S-transferase in mice. J Med Chem 30 (1987) 1399-1403
11. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37 (2004) 277-285
12. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37 (2004) 112-119
13. Wen X., Takenaka M., Murata M., and Homma S. Antioxidative activity of a zinc-chelating substance in coffee. Biosci Biotechnol Biochem 68 (2004) 2313-2318
14. Gross G., Jaccaud E., and Huggett A.C. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol 35 (1997) 547-554
15. Satoh K., Takamatsu S., Sakuta S., Mizuno S., Metoki H., and Takamatsu M. Augmented malondialdehyde production by platelets from patients with cerebrovascular disorders. Jpn Circ J 45 (1981) 1335-1341
16. Yagi K., Matsuoka S., Linnane A.W., and Zimmet P. Plasma lipid peroxide levels in an urbanized Micronesian population. Nauru J Nutr Sci Vitaminol 27 (1981) 425-428
17. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
18. Hu M.I., Louie S., Cross C.E., Motchnik P., and Halliwell B. Antioxidant protection against hydrochlorous acid in human plasma. J Lab Clin Med 12 (1993) 257-262
19. Sunderman F.W., and Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 16 (1970) 903-910
20. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 44 (1998) 2313-2319
21. Nanji A.A., Yang E.K., Fogt F., Sadrzadeh S.M.H., and Dannenberg A.J. Medium chain triglycerides and Vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharm Exp Ther 277 (1996) 1694-1699
22. 4-induced liver injury in mice and its possible mechanisms. World J Gastroenterol 11 (2005) 5795-5800
23. Recknagel R., Glende E.A., Dolak J.A., and Waller R.L. Mechanisms of carbon tetrachloride toxicity. Pharm Ther 43 (1989) 139-154
24. Slater T.F. Free radicals as reactive intermediates in injury. In: Snyder R., Parke D.V., Kocsis J.J., Jollow D.J., Gebson G.G., and Witmer C.M. (Eds). Biological reactive intermediates II: chemical mechanisms and biological effects (1982), Plenum Press, New York 575-589
25. Brattin W.J., Glende E.A., and Recknagel R.O. Pathological mechanisms in carbon tetrachloride hepatotoxicity. J Free Radic Biol Med 1 (1985) 27-28
26. Nadkarni G.D., and Souza N.B. Hepatic antioxidant enzymes and lipid peroxidation in carbon tetrachloride-induced liver cirrhosis in rats. Biochem Med Met Biol 40 (1988) 42-45
27. Parola M., Rubio M., Varela G., et al. Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J Hepatol 25 (1996) 2000-2005
28. Edwards M.J., Keller B.J., Kaufman F.C., and Thurman R.G. The involvement of kupffer cells in carbon tetrachloride toxicity. Toxicol Appl Pharmacol 119 (1993) 275-279
29. Fuhrman B., and Aviram M. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol 12 (2001) 41-48
30. Kanter M., Coskun O., and Budancamanak M. Hepatoprotective effects of Nigella sativa L. and Urtica dioica L. on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World J Gastroenterol 11 (2005) 6684-6688
31. Rodriguez R.J., Miranda C.L., Stevens J.F., Deinzer M.L., and Buhler D.R. Influence of prenylated and non-prenylated flavonoids on liver microsomal lipid peroxidation and oxidative injury in rat hepatocytes. Food Chem Toxicol 39 (2001) 437-445
32. 4) baǧli{dotless} karaciǧer hasari{dotless} ve plazma Paroksonaz ile Arilesteraz aktivite düzeylerine olan etkileri. FU Sag Bil Derg 19 (2005) 263-271
33. Abraham S.K., and Sing S.P. Anti-genotoxicity and glutathion S-transferase activity in mice pretreated with caffeinated and decaffeinated coffee. Food Chem Toxicol 37 (1999) 733-739
34. Homma S. Non-volatile compounds. In: Clarcke R., and Jand Vitzthum O.G. (Eds). Coffee (2001), Blackwell Scientific, London 50-67
35. Delgado-Andrade C., Rufian-Henares J.A., and Morales F.J. Assessing the antioxidant activity of melanoidins from coffee brews by different antioxidant methods. J Agric Food Chem 53 (2005) 7832-7836
36. Boekschoten M.V., Schouten E.G., and Katan M.B. Coffee bean extracts rich and poor in kahweol both give rise to elevation of liver enzymes in healthy volunteers. Nutr J 3 (2004) 7
37. Ruhl C.E., and Everhart J.E. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129 (2005) 1928-1936
38. Nakanishi N., Nakamura K., Suzuki K., and Tatara K. Effects of coffee consumption against the development of liver dysfunction: a 4-year follow-up study of middle-aged Japanese male office workers. Ind Health 38 (2000) 99-102
39. Kono S., Shinchi K., Imanishi K., Todoroki I., and Hatsuse K. Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan. Am J Epidemiol 139 (1994) 293-297
40. Klatsky A.L., and Armstrong M.A. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 136 (1992) 1248-1257
41. Terpstra A.H., Katan M.B., Weusten-van der Wouw M.P., de Roos B., and Beynen A.C. The hypercholesterolemic effect of cafestol in coffee oil in gerbils and rats. J Nutr Biochem 11 (2000) 311-317
42. Roos B.D., Tol A.V., Urgert R., et al. Consumption of French-press coffee raises cholesteryl ester transfer protein activity levels before LDL cholesterol in normolipidemic subjects. J Int Med 248 (2000) 211-216
43. Weusten-Van der Wouw M.P., Katan M.B., Viani R., et al. Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes. J Lipid Res 35 (1994) 721-733
44. Van Dusseldorp M., Katan M.B., van Vliet T., Demacker P.N., and Stalenhoef A.F. Cholesterol-raising factor from boiled coffee does not pass a paper filter. Arterioscler Thromb 11 (1991) 586-593
45. Ahola I., Jauhiainen M., and Aro A. The hypercholesterolaemic factor in boiled coffee is retained by a paper filter. J Int Med 230 (1991) 293-297
46. Urgert R., and Katan M.B. The cholesterol-raising factor from coffee beans: review. Ann Rev Nutr 17 (1997) 305-324